Tuberculosis in children: Difference between revisions
Line 70: | Line 70: | ||
▸ '''[[Ethionamide]] 15-20 mg/kg divided q12h (Max: 1000 mg)'''<br> OR <br> ▸ '''[[Protionamide]] 15-20 mg/kg divided q12h (Max: 1000 mg)''' <br> OR <br> ▸ '''[[Cycloserine]] 10-20 mg/kg (Max: 1000 mg)'''<br> OR <br> ▸ '''[[Terizidone]] 10-20 mg/kg (Max: 1000 mg)'''<br> OR <br> ▸ '''[[Aminosalicylic acid|Para-aminosalicylic acid]] 150 mg/kg divided q8-12h(Max: 12 000 mg)''' | ▸ '''[[Ethionamide]] 15-20 mg/kg divided q12h (Max: 1000 mg)'''<br> OR <br> ▸ '''[[Protionamide]] 15-20 mg/kg divided q12h (Max: 1000 mg)''' <br> OR <br> ▸ '''[[Cycloserine]] 10-20 mg/kg (Max: 1000 mg)'''<br> OR <br> ▸ '''[[Terizidone]] 10-20 mg/kg (Max: 1000 mg)'''<br> OR <br> ▸ '''[[Aminosalicylic acid|Para-aminosalicylic acid]] 150 mg/kg divided q8-12h(Max: 12 000 mg)''' | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=left |<small>Table adapted from WHO 2013 Treatment of tuberculosis: guidelines – 4th ed.<ref name="WHO 2013"> {{cite web| url=http://www.who.int/tb/publications/tb_treatmentguidelines/en/| title=2013 WHO Treatment of Tuberculosis: Guidelines for National Programmes (4th Edition) }}</ref> and Guidance for national tuberculosis programmes on the management of tuberculosis in children <ref name="WHO Children"> {{cite web| url=http:// | | style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=left |<small>Table adapted from WHO 2013 Treatment of tuberculosis: guidelines – 4th ed.<ref name="WHO 2013"> {{cite web| url=http://www.who.int/tb/publications/tb_treatmentguidelines/en/| title=2013 WHO Treatment of Tuberculosis: Guidelines for National Programmes (4th Edition) }}</ref> and Guidance for national tuberculosis programmes on the management of tuberculosis in children <ref name="WHO TB Children"> {{cite web |url=http://apps.who.int/iris/bitstream/10665/112360/1/9789241548748_eng.pdf| title=WHO Guidance for national tuberculosis programmes on the management of tuberculosis in children, 2014}} </ref></small> | ||
|} | |} | ||
|} | |} | ||
Line 93: | Line 93: | ||
▸ '''[[Clofazimine]] 50 mg/d AND 300 mg once a month'''<br> OR <br> ▸ '''[[Amoxicillin]]/[[clavulanate]]''' <br> OR <br> ▸ '''[[Linezolid]] 300-600 mg'''<br> OR <br> ▸ '''[[Imipenem]] 500mg q6h'''<br> OR <br>▸ '''[[Clarithromycin]] 500-1000 mg q12h '''<br> OR <br>▸ '''[[Thioacetazone]] 2.5 mg/kg'''<br> OR <br>▸ '''[[Isoniazid]] (high-dose) 16–20 mg/kg''' | ▸ '''[[Clofazimine]] 50 mg/d AND 300 mg once a month'''<br> OR <br> ▸ '''[[Amoxicillin]]/[[clavulanate]]''' <br> OR <br> ▸ '''[[Linezolid]] 300-600 mg'''<br> OR <br> ▸ '''[[Imipenem]] 500mg q6h'''<br> OR <br>▸ '''[[Clarithromycin]] 500-1000 mg q12h '''<br> OR <br>▸ '''[[Thioacetazone]] 2.5 mg/kg'''<br> OR <br>▸ '''[[Isoniazid]] (high-dose) 16–20 mg/kg''' | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=left |<small>Table adapted from WHO 2013 Treatment of tuberculosis: guidelines – 4th ed.<ref name="WHO 2013"> {{cite web| url=http://www.who.int/tb/publications/tb_treatmentguidelines/en/| title=2013 WHO Treatment of Tuberculosis: Guidelines for National Programmes (4th Edition) }}</ref> and WHO Guidance for national tuberculosis programmes on the management of tuberculosis in children <ref name="WHO TB Children"> {{cite web| url=http://apps.who.int/iris/bitstream/10665/112360/1/9789241548748_eng.pdf| title=WHO Guidance for national tuberculosis programmes on the management of tuberculosis in children, 2014}} </ref></small> | | style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=left |<small>Table adapted from WHO 2013 Treatment of tuberculosis: guidelines – 4th ed.<ref name="WHO 2013"> {{cite web| url=http://www.who.int/tb/publications/tb_treatmentguidelines/en/| title=2013 WHO Treatment of Tuberculosis: Guidelines for National Programmes (4th Edition) }}</ref> and WHO Guidance for national tuberculosis programmes on the management of tuberculosis in children <ref name="WHO TB Children"> {{cite web |url=http://apps.who.int/iris/bitstream/10665/112360/1/9789241548748_eng.pdf| title=WHO Guidance for national tuberculosis programmes on the management of tuberculosis in children, 2014}} </ref></small> | ||
|} | |} | ||
|} | |} |
Revision as of 14:32, 23 September 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]
Tuberculosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Tuberculosis in children On the Web |
American Roentgen Ray Society Images of Tuberculosis in children |
Risk calculators and risk factors for Tuberculosis in children |
Overview
Tuberculosis in Children
Treatment Regimens
Tuberculosis in Children ▸ Drug Susceptible TB Regimen ▸ MDR-TB ▸ XDR-TB |
|